About Us
Diabetes Education
Printer FriendlyGlobal Advanced Therapeutics and Technologies in
Diabetes Care: Incorporating Incretin-based
Therapies into Clinical Practice
A medical education program specifically for doctors who practice
outside of the United States
 |
|
2009 Dates
October 12, 13 and 14, 2009
November 9, 10 and 11, 2009
(Note: There must be a minimum of 10 participants registered
per program)
2010 Dates
February 15, 16 and 17, 2010
May 3, 4 and 5, 2010
May 24, 25 and 26, 2010
August 23, 24 and 25, 2010
October 4, 5 and 6, 2010
November 15, 16 and 17, 2010
(Note: There must be a minimum of 10 participants registered per program)
Location
International Diabetes Center
Park Nicollet Clinic—St. Louis Park
3800 Park Nicollet Blvd.
St. Louis Park, Minn.
Audience
Primary care doctors specializing in diabetes, and endocrinologists (not practicing in the United States). Those doctors who are involved in developing diabetes care guidelines and practices for health care systems and public health agencies in their countries may find this program especially useful.
Description
This three-day intensive, specialized program meets the unique needs of international physicians by discussing recent advances in therapies and technologies for managing glucose control in patients with type 2 diabetes. The customized program teaches practicing doctors how to select appropriate candidates, start and adjust treatment, and monitor changes in glycemic control using advanced therapies focusing on incretin-based therapies. Opportunities to interact with patients who have experience with advanced therapies and technologies will be provided. IDC faculty work closely with participants throughout the program and are available during program breaks and meals for in-depth discussions. More..
Tuition
US $2,000 per participant.
To register or request additional information, contact:Dina Melnik, Senior Program Coordinator
International Diabetes Center
E-mail: dina.melnik@parknicollet.com
Phone: 952-993-1107
Fax: 952-993 -1302
